Press releases.

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014

Dec 01, 2021

News

IR

English

Corporate Information

Sales

Order

SenzaGen receives SEK 1m follow-on order for GARD®skin Dose-Response from one of the world’s largest cosmetics companies

Nov 02, 2021

News

IR

English

Regulatory

Listing Regulation

Corporate Action

Shares

Issuance

SenzaGen has completed the acquisition of VitroScreen S.r.l.

Oct 29, 2021

News

IR

English

Regulatory

MAR

Corporate Action

Shares

Issuance

SenzaGen completes a directed share issue of SEK 30 million

Oct 28, 2021

News

IR

English

Regulatory

MAR

Corporate Action

Shares

Issuance

SenzaGen intends to carry out a directed share issue

Oct 28, 2021

News

IR

English

Regulatory

MAR

Corporate Action

M&A

SenzaGen enters into agreement to acquire 100 percent of the shares in VitroScreen

Sep 29, 2021

News

IR

English

Regulatory

Listing Regulation

Corporate Information

Other Corporate Information

SenzaGen presents accelerated growth strategy and invitation to Capital Markets Day

Aug 24, 2021

News

IR

English

Corporate Information

Sales

Order

SenzaGen receives SEK 0.7m order for GARD®skin from one of the world’s largest pharmaceuticals companies

Aug 19, 2021

News

IR

English

Regulatory

MAR

Report

Interim

Q2

SenzaGen’s 2021 Half-Year Report: Positive ESAC opinion on GARD®skin and expanded range of tests open up new commercial opportunities

Aug 18, 2021

News

IR

English

Regulatory

MAR

Corporate Information

Staff change

SenzaGen appoints Peter Nählstedt as new CEO

Aug 12, 2021

News

IR

English

Corporate Information

Other Corporate Information

Invitation to SenzaGen’s 2021 half year report conference call on Aug 19 at 10.30 CET

Aug 06, 2021

News

IR

English

Corporate Information

Sales

Order

SenzaGen receives SEK 0.65 million order for in vitro skin allergy and irritation tests from global consumer product company

Jul 26, 2021

News

IR

English

Regulatory

MAR

Corporate Information

Other Corporate Information

Positive scientific ESAC opinion on GARD®skin paves the way for OECD validation and opens new commercial opportunities

Jul 12, 2021

News

IR

English

Corporate Information

Sales

Order

SenzaGen and RIFM begin part two of the GARD®skin Dose-Response program

Jul 09, 2021

News

IR

English

Corporate Information

Sales

Order

SenzaGen receives SEK 0.65 million order for GARD®skin Dose-Response from one of the world's leading cosmetics companies

May 24, 2021

News

IR

English

Corporate Information

Other Corporate Information

SenzaGen expands services within in vitro skin toxicology

May 05, 2021

News

IR

English

Regulatory

Listing Regulation

Corporate Information

General meeting

Report of the AGM

Report from AGM of SenzaGen AB on 5 May 2021

Mar 26, 2021

News

IR

English

Regulatory

Listing Regulation

Corporate Information

General meeting

Notice

NOTICE OF ANNUAL GENERAL MEETING OF SENZAGEN AB (Publ)

Mar 25, 2021

News

IR

English

Regulatory

Listing Regulation

Report

Annual

SenzaGen’s Annual Report 2020 published

Mar 04, 2021

News

IR

English

Corporate Information

Sales

Order

SenzaGen and RIFM expand collaboration on the safe use of fragrances with GARD™skin Dose-Response

Feb 26, 2021

News

IR

English

Corporate Information

Sales

Order

SenzaGen secures SEK 0.6 m order from a new European customer in the chemical industry

Subscribe

English

Swedish

Reports

Press releases

Prenumerera